Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:31 PM
Ignite Modification Date:
2025-12-24 @ 10:31 PM
NCT ID:
NCT00454935
Eligibility Criteria:
Inclusion Criteria:
* age \> 18 years
* suffering from partial seizures, with or without secondary generalisation
* must have undergone surgery for their newly diagnosed or recurrent glioma not more than 42 days previously
* treated with levetiracetam
* histologically proven astrocytoma grade II or III, oligodendroglioma grade II or III, oligoastrocytoma grade II or III, or glioblastoma multiforme according to the World Health Organisation (WHO) classification of tumours affecting the central nervous system
* written informed consent
Exclusion Criteria:
* Women who are pregnant or lactating
* Patients who do not have a basic proficiency of the Dutch language,or are unable to communicate adequately will also be excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00454935
Study Brief:
Protocol Section:
NCT00454935